FR3058417B1 - Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant - Google Patents

Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant Download PDF

Info

Publication number
FR3058417B1
FR3058417B1 FR1660744A FR1660744A FR3058417B1 FR 3058417 B1 FR3058417 B1 FR 3058417B1 FR 1660744 A FR1660744 A FR 1660744A FR 1660744 A FR1660744 A FR 1660744A FR 3058417 B1 FR3058417 B1 FR 3058417B1
Authority
FR
France
Prior art keywords
glycosides
amides
derivatives
composition containing
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1660744A
Other languages
English (en)
Other versions
FR3058417A1 (fr
Inventor
Marie Celine Frantz
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1660744A priority Critical patent/FR3058417B1/fr
Priority to PCT/EP2017/078485 priority patent/WO2018083344A1/fr
Priority to US16/347,315 priority patent/US20190263770A1/en
Priority to JP2019522285A priority patent/JP7490362B2/ja
Priority to CN201780081538.1A priority patent/CN110114347A/zh
Priority to EP17800770.4A priority patent/EP3535251A1/fr
Publication of FR3058417A1 publication Critical patent/FR3058417A1/fr
Application granted granted Critical
Publication of FR3058417B1 publication Critical patent/FR3058417B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé de traitement cosmétique de la peau, comprenant l'application sur la peau, d'une composition comprenant un composé (I) Avec R tel que défini dans la description et S* un mono ou polysaccharide.
FR1660744A 2016-11-07 2016-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant Active FR3058417B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1660744A FR3058417B1 (fr) 2016-11-07 2016-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant
PCT/EP2017/078485 WO2018083344A1 (fr) 2016-11-07 2017-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant
US16/347,315 US20190263770A1 (en) 2016-11-07 2017-11-07 Method for the treatment of keratin materials using acid, ester or amide c-glycoside derivatives, and cosmetic composition containing same
JP2019522285A JP7490362B2 (ja) 2016-11-07 2017-11-07 酸、エステル、又はアミドｃ－グリコシド誘導体を使用するケラチン物質の処理の方法及びそれを含む化粧用組成物
CN201780081538.1A CN110114347A (zh) 2016-11-07 2017-11-07 使用酸、酯或酰胺c-糖苷衍生物以及含有其的化妆品组合物处理角蛋白材料的方法
EP17800770.4A EP3535251A1 (fr) 2016-11-07 2017-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1660744 2016-11-07
FR1660744A FR3058417B1 (fr) 2016-11-07 2016-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant

Publications (2)

Publication Number Publication Date
FR3058417A1 FR3058417A1 (fr) 2018-05-11
FR3058417B1 true FR3058417B1 (fr) 2019-02-01

Family

ID=57539548

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1660744A Active FR3058417B1 (fr) 2016-11-07 2016-11-07 Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant

Country Status (1)

Country Link
FR (1) FR3058417B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3083109B1 (fr) * 2018-06-29 2020-05-29 L'oreal Procede de traitement des matieres keratiniques par des composes c-glycosides5-oxazolidine-2,4-diones, composes et composition cosmetique les contenant
FR3083108B1 (fr) * 2018-06-29 2020-05-29 L'oreal Utilisation de derives c-glycosides 5-oxazolidine-2,4-diones a titre d’agent hydratant de la peau »

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622448B2 (en) * 2003-04-08 2009-11-24 L'oreal Compositions suitable for topical application to the skin
FR2899467B1 (fr) * 2006-04-07 2008-05-30 Oreal Utilisation de derive c-glycosides comme agent protecteur et/ou activateur des lymphocytes gamma delta t
FR2899468B1 (fr) * 2006-04-07 2008-05-30 Oreal Utilisation de c-glycosides derives de galactose comme agent protecteur et/ou activateur des lumphocytes gamma delta t
FR3035787B1 (fr) * 2015-05-07 2018-08-24 L'oreal Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, acides ou ester, et la composition cosmetique les contenant

Also Published As

Publication number Publication date
FR3058417A1 (fr) 2018-05-11

Similar Documents

Publication Publication Date Title
MX2017010544A (es) Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo.
EA202090871A1 (ru) Ингибирование убиквитин-специфической пептидазы 30
MX2016003582A (es) Compuesto inhibidor de las actividades de las cinasas btk y/o jak3.
MA35920B1 (fr) Composés destinés au traitement de l'amyotrophie spinale
EA201000603A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
EA201791993A1 (ru) Способы лечения протеинопатий
MA47356B1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
EA201891228A1 (ru) Изделие, содержащее целлюлозу, изготовленную биотехнологическим способом, для дерматологического применения
TR201904514T4 (tr) Makrosiklik LRRK2 kinaz inhibitörleri.
MA39171A1 (fr) Dérivés d'hydroxy formamide et leur utilisation
MA46459B1 (fr) Méthode de traitement de lésions rénales aiguës
FR3035787B1 (fr) Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, acides ou ester, et la composition cosmetique les contenant
MX2016006763A (es) Inhibidores de tirosina cinasa de bruton.
MX2016006744A (es) Inhibidores de tirosina cinasa de bruton.
FR3058417B1 (fr) Procede de traitement des matieres keratiniques a partir de derives de c-glycosides acides, esters ou amides, et la composition cosmetique les contenant
MX2022001084A (es) Metodo de tratamiento de la enfermedad de alzheimer mediante la regulacion de microrganismos intestinales.
EA201170849A1 (ru) Применение 5-пиридин-4-ил(1,3)тиазолов для борьбы с фитопатогенными грибами
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение
MX2016006351A (es) Inhibidores de tirosina cinasa de bruton.
PH12021550055A1 (en) Prevention or treatment method for peripheral neuropathy or pain accompanying disease in which peripheral neuropathy or astrocyte disorder is recognized
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
WO2017223514A8 (fr) Agonistes inverses de lxr pour le traitement du cancer
EA202091653A1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
FR3058416B1 (fr) Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, et la composition cosmetique les contenant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180511

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8